The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGILE THERAPEUTICS INC | COMM | 00847L100 | 634 | 220,852 | SH | SOLE | 220,852 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 10,863 | 2,221,453 | SH | SOLE | 2,221,453 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 5,394 | 107,900 | SH | Call | SOLE | 107,900 | 0 | 0 | |
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 5,604 | 112,100 | SH | Call | SOLE | 112,100 | 0 | 0 | |
AWARE INC MASS | COMM | 05453N100 | 6,387 | 1,824,854 | SH | SOLE | 1,824,854 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COMM | 09058V103 | 4,007 | 537,866 | SH | SOLE | 537,866 | 0 | 0 | ||
BLOOMIN BRANDS INC | COMM | 094235108 | 11,950 | 615,367 | SH | SOLE | 615,367 | 0 | 0 | ||
BLUEKNIGHT ENERGY PARTNERS L | COM UNIT | 09625U109 | 4,846 | 2,447,437 | SH | SOLE | 2,447,437 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COMM | 101137107 | 4,157 | 115,620 | SH | SOLE | 115,620 | 0 | 0 | ||
BRINKER INTL INC | COMM | 109641100 | 11,628 | 205,559 | SH | SOLE | 205,559 | 0 | 0 | ||
CAESARS ENTERTAINMENT INC NE | COMM | 12769G100 | 9,768 | 131,516 | SH | SOLE | 131,516 | 0 | 0 | ||
COHN ROBBINS HOLDINGS CORP | COM CL A | G23726105 | 1,047 | 100,549 | SH | SOLE | 100,549 | 0 | 0 | ||
CORNER GROWTH ACQUISITION CO | UNIT 01/01/2027 | G2425N121 | 1,568 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
DARDEN RESTAURANTS INC | COMM | 237194105 | 9,530 | 80,000 | SH | Call | SOLE | 80,000 | 0 | 0 | |
EVERI HOLDINGS INC | COMM | 30034T103 | 15,071 | 1,091,312 | SH | SOLE | 1,091,312 | 0 | 0 | ||
EXTENDED STAY AMERICA INC | UNIT 99/99/9999B | 30224P200 | 13,932 | 940,691 | SH | SOLE | 940,691 | 0 | 0 | ||
FIRSTENERGY CORP | COMM | 337932107 | 3,061 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
FIRSTENERGY CORP | COMM | 337932107 | 2,599 | 84,900 | SH | Call | SOLE | 84,900 | 0 | 0 | |
FRAZIER LIFESCIENCES ACQU CO | UNIT 12/09/2025 | G3710A121 | 4,685 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 13,285 | 181,614 | SH | SOLE | 181,614 | 0 | 0 | ||
INVACARE CORP | NOTE 5.000%11/1 | 461203AL5 | 15,579 | 15,975,000 | PRN | SOLE | 15,975,000 | 0 | 0 | ||
LIFETIME BRANDS INC | COMM | 53222Q103 | 298 | 19,575 | SH | SOLE | 19,575 | 0 | 0 | ||
NANTHEALTH INC | NOTE 5.500%12/1 | 630104AB3 | 6,549 | 6,815,000 | PRN | SOLE | 6,815,000 | 0 | 0 | ||
NEBULA CARAVEL ACQUISITION C | UNIT 12/09/2023 | 629070202 | 270 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
OSMOTICA PHARMACEUTICALS PLC | SHS | G6S41R101 | 2,106 | 511,063 | SH | SOLE | 511,063 | 0 | 0 | ||
PROVENTION BIO INC | COMM | 74374N102 | 7,510 | 443,331 | SH | SOLE | 443,331 | 0 | 0 | ||
RICEBRAN TECHNOLOGIES | COM NEW | 762831204 | 780 | 1,279,319 | SH | SOLE | 1,279,319 | 0 | 0 | ||
ROMAN DBDR TECH ACQUISITION | COM CL A | 77584N101 | 4,044 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ROMAN DBDR TECH ACQUISITION | *W EXP 10/31/202 | 77584N119 | 2,022 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SCION TECH GROWTH I | UNIT 12/17/2025 | G31067120 | 4,136 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SPARTACUS ACQUISITION CORP | UNIT 10/31/2027 | 84677L208 | 529 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SPARTACUS ACQUISITION CORP | CL A | 84677L109 | 4,024 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SPARTACUS ACQUISITION CORP | *W EXP 10/31/202 | 84677L117 | 2,012 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SUMMIT MATLS INC | CL A | 86614U100 | 10,799 | 537,805 | SH | SOLE | 537,805 | 0 | 0 | ||
THAYER VENTURES ACQU CORP | UNIT 01/01/2030 | 88332T209 | 8,360 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
TURNING PT BRANDS INC | COMM | 90041L105 | 6,794 | 152,463 | SH | SOLE | 152,463 | 0 | 0 | ||
TURNING PT BRANDS INC | NOTE 2.500% 7/1 | 90041LAE5 | 718 | 640,000 | PRN | SOLE | 640,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COMM | 91307C102 | 14,180 | 93,416 | SH | SOLE | 93,416 | 0 | 0 | ||
WYNDHAM HOTELS & RESORTS INC | COMM | 98311A105 | 5,677 | 95,500 | SH | SOLE | 95,500 | 0 | 0 |